NEW YORK, June 04, 2020 (GLOBE NEWSWIRE) -- The latest Depression Screening Market study by Data Bridge Market Research offers an all-inclusive, in-depth analysis of the major strategies, corporate models, and market shares of the prominent players of the Depression Screening Market. The Global report provides a thorough examination of the major driving factors, market figures in terms of revenues, segmental data, regional data, and country-wise data. This study can be described as an exhaustive database that comprises all the aspects of the evolving Depression Screening Market.
Market Analysis: Global Depression Screening Market
Global Depression Screening Market is expected to rise from its initial estimated value of USD 9043.06 million in 2018 to an estimated value of USD 12968.84 million by 2026 registering a CAGR of 4.61% in the forecast period of 2019-2026. This rise in the market can be attributed to the growing patient population with the medical conditions such as anxiety, depressions and mental disorders.
To Get a Sample Copy of the Report, along with the TOC, Statistics, and Tables, Please Visit at https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-depression-screening-market
Leading Depression Screening Market manufacturers/companies operating at both regional and global levels:
- Johnson & Johnson Services Inc.,
- AstraZeneca,
- Bristol-Myers Squibb Company,
- Eli Lilly and Company,
- F. Hoffmann-La Roche Ltd.,
- Novartis AG,
- Otsuka Holdings Co.,Ltd.,
- Pfizer Inc.,
- GlaxoSmithKline plc,
- Alkermes,
- ALLERGAN,
- Janssen Global Services, LLC.,
- Solvay,
- Meiji Holdings Company, Ltd.,
- Abbott,
- Jazz Pharmaceuticals, Inc.,
- AbbVie Inc.,
- Vertical Pharmaceuticals, LLC,
- ACADIA Pharmaceuticals Inc.,
- Medtronic,
- Bausch Health.,
- Validus Pharmaceuticals LLC,
- Alfasigma USA Inc.,
- Merck KGaA,
- Island Health,
- Homewood Health, Inc.,
- ROYAL OTTAWA HEALTH CARE GROUP,
- CAMH.
Access full Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-depression-screening-market
Global Depression Screening Market By Disease Type (Anxiety, Mood Disorders, Depression, Bipolar Disorders, Psychotic Disorders, Eating Disorders, Other Disorders), By Diagnosis (Psychological Test, Lab Tests, Depression Screening Tests, Others), Treatment (Medication, Brain-Stimulation Treatments, Deep Brain Stimulation) and End User (Hospitals & Clinics, Medical Research Centers, Academic Institutes, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa) – Industry Trends & Forecast to 2026
Read Continue @ https://www.databridgemarketresearch.com/reports/global-depression-screening-market
In November 2018, The Health Department announced the launch of their new campaign whose main aim is expand the treatment and screening of depression in primary care setting. The campaign main motive is to fill the gap between the care taker centers and hospitals and help the providers to guide how they can ask the patients about the common symptoms of depression. This campaign will help people to be more open about their problems with the doctors and get better treatment.
In October 2017, Cedars-Sinai Medical Center announced the launch of their new Postpartum Depression Screening Program which is specially designed for new mothers. In this, two days after giving birth new mothers have to answer 9 questions which will help the doctor to analyze whether there are any symptoms of the postpartum depression or not. The main aim of the program is to provide good treatment and care to the patients if they are suffering from such depression.
Market Definition: Global Depression Screening Market
Depression is a serious medical illness. It may lead to various psychotherapeutic conditions which can be classified as abnormal behavior, thoughts and feelings. These abnormal conditions sometimes occur for specific amount of time, which leads to distress or emotional or physical impairment. The causes of mental disorders are often unclear. The screening consist of physical exam is usually to rule out another medical cause for depression. The depression screening majorly focuses on neurological and endocrine systems.
Market Drivers Global Depression Screening Market
- Increasing cases of mental disorders is driving the growth of this market
- Rise in adoption of new therapies and treatments is another factor driving market
Market Restraints Global Depression Screening Market
- Less awareness among population about mental health disorders is restraining the market
- Less availability of treatment related to depression in the developing countries is another important factor restraining market.
Segmentation Global Depression Screening Market
- By Disease Type
- Anxiety
- Mood Disorders
- Depression
- Bipolar Disorders
- Psychotic Disorders
- Eating Disorders
- Other Disorders
- By Diagnosis
- Psychological Test
- Lab Tests
- Depression Screening Tests
- Others
- By Treatment
- Medication
- Anti-Anxiety Medications
- Antidepressants
- Antipsychotic Medications
- Stimulants
- Anti-Seizures Medications
- Others
- Brain-Stimulation Treatments
- Vagus Nerve Stimulation (VNS)
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- Magnetic Seizure Therapy (MST)
- Deep Brain Stimulation
- Medication
- By End User
- Hospitals
- Specialized Clinics
- Ambulatory Surgical Centers
- Others
- By Geography
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Reasons to Purchase this Report
- Current and Future of Depression Screening Market Outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Key Highlights of Report
- Overview of key market forces propelling and restraining market growth
- Offers a clear understanding of the competitive landscape and key product segments
- An analysis of strategies of major competitors
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Provides profiles of major competitors of the market.
- Details of their operations, product and services.
- Recent developments and key financial metrics.
The research provides answers to the following key questions:
- What is the estimated growth rate of the market for the forecast period? What will be the market size during the estimated period?
- What are the key driving forces responsible for shaping the fate of the Global Depression Screening Market) market during the forecast period?
- Who are the major market players, and what are the winning strategies that have helped them occupy a strong foothold in the Global Depression Screening Market?
- What are the current market trends influencing the development of the Global Depression Screening Market across different regions?
- What are the major threats and challenges that are expected to hinder the growth of the Global Depression Screening Market?
- What are the major growth opportunities that the key market leaders can rely on to gain success and profitability?
To get this Report at Incredible Discounts, Click here https://www.databridgemarketresearch.com/request-a-discount/global-depression-screening-market
Browse Related Report
Global Drug Screening Market By Products and Services [Equipment (Immunoassay Analyzers, Chromatography Instruments, and Breath Analyzers {Semiconductor Breath Analyzers and Fuel Cell Analyzers}, Rapid Testing Devices(RTD) {Oral Fluid Testing Devices and Urine Testing Devices}), Consumables {Assay Kits, Calibrators & Controls, and Sample Collection Cups} and Laboratory Services], Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat), End User (Workplace & Schools, Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, and Pain Management Centers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-drug-screening-market
Global Blood Screening Market, By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) - Industry Trends and Forecast to 2025 https://www.databridgemarketresearch.com/reports/global-blood-screening-market
Global High Content Screening Market By Product (Instruments, Consumables, Software, Services, Accessories), Application (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling, Other Applications), End- User (Pharmaceutical and Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-high-content-screening-market
Global Newborn Screening Market By Test Type (Dried Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test), Product Type (Instruments, Reagents and Assay Kits), Technology (Tandem Mass Spectrometry, Hearing Screen Technology, Pulse Oximetry Screening Technology, Immunoassays and Enzymatic Assays, Electrophoresis, DNA-Based Assays), Disease Type (Critical Congenital Heart Diseases, Newborn Hearing Loss, Sickle Cell Disease, Phenylketonuria (PKU), Cystic Fibrosis (CF), Maple Syrup Urine Disease, Others), End User (Hospital, Paediatric Clinics, Clinics), Geography (Europe, North America, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-newborn-screening-market
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: corporatesales@databridgemarketresearch.com